| [1] |
朱有华, 曾力.肾移植[M].北京:人民卫生出版社, 2017.
|
| [2] |
陈实, 石炳毅.临床技术操作规范:器官移植分册[M].北京:人民军医出版社, 2010.
|
| [3] |
刘永锋, 郑树森.器官移植学[M].北京:人民卫生出版社, 2014.
|
| [4] |
MORRIS P, KNECHTLE S. Kidney transplantation (7th edition) [M]. Philadelphia: Saunders, 2014.
|
| [5] |
DE FIJTER JW. Recurrence of glomerulonephritis: an underestimated and unmet medical need[J]. Kidney Int, 2017, 92(2):294-296. DOI: 10.1016/j.kint.2017.04.007.
|
| [6] |
NESTER CM, J FALK R. Introduction: glomerular disease update for the clinician[J]. Clin J Am Soc Nephrol, 2016, 11(9):1662-1663. DOI: 10.2215/CJN. 07430716.
|
| [7] |
MAGISTRONI R, CAPOLONGO G, PISCOPO G. Renal failure, management of uremic condition and replacement therapy[J]. G Ital Nefrol, 2016, 33(5). https://www.ncbi.nlm.nih.gov/pubmed/27796019
|
| [8] |
LADHANI M, CRAIG JC, IRVING M, et al. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and Meta-analysis[J]. Nephrol Dial Transplant, 2017, 32(3):439-449. DOI: 10.1093/ndt/gfw075.
|
| [9] |
NEVINS TE, NICKERSON PW, DEW MA. Understanding medication nonadherence after kidney transplant[J].J Am Soc Nephrol, 2017, 28(8):2290-2301. DOI: 10.1681/ASN.2017020216.
|
| [10] |
NERINI E, BRUNO F, CITTERIO F, et al. Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? [J]. J Nephrol, 2016, 29(5):627-636. DOI: 10.1007/s40620-016-0273-x.
|
| [11] |
SCHEEL J, REBER S, STOESSEL L, et al. Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation[J]. BMC Nephrol, 2017, 18(1):107. DOI: 10.1186/s12882-017-0517-6.
|
| [12] |
JABBARI B, VAZIRI ND. The nature, consequences, and management of neurological disorders in chronic kidney disease[J]. Hemodial Int, 2018, 22(2):150-160. DOI: 10.1111/hdi.12587.
|
| [13] |
KRANSDORF EP, PANDO MJ. Calculated panel reactive antibody with decimals: a refined metric of access to transplantation for highly sensitized candidates[J]. Hum Immunol, 2017, 78(3):252-256. DOI: 10.1016/j.humimm.2016.12.009.
|
| [14] |
AKGUL SU, CIFTCI HS, TEMURHAN S, et al. Association between HLA antibodies and different sensitization events in renal transplant candidates[J]. Transplant Proc, 2017, 49(3):425-429. DOI: 10.1016/j.transproceed.2017.02.004.
|
| [15] |
PROFAIZER T, KUMÁNOVICS A. Human leukocyte antigen typing by next-generation sequencing[J]. Clin Lab Med, 2018, 38(4):565-578. DOI: 10.1016/j.cll.2018.07.006.
|
| [16] |
PROFAIZER T, LÁZÁR-MOLNÁR E, CLOSE DW, et al.HLA genotyping in the clinical laboratory: comparison of next-generation sequencing methods[J]. HLA, 2016, 88(1/2):14-24. DOI: 10.1111/tan.12850.
|
| [17] |
CHONG HJ, KIM HK, KIM SR, et al. Waiting for a kidney transplant: the experience of patients with end-stage renal disease in South Korea[J]. J Clin Nurs, 2016, 25(7/8):930-939. DOI: 10.1111/jocn.13107.
|
| [18] |
ROSA-DIEZ G, GONZALEZ-BEDAT M, FERREIRO A, et al. Burden of end-stage renal disease (ESRD) in Latin America[J]. Clin Nephrol, 2016, 86(13):29-33. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=WK_MED201904220707
|
| [19] |
EISENGA MF, MINOVIĆ I, BERGER SP, et al. Iron deficiency, anemia, and mortality in renal transplant recipients[J]. Transpl Int, 2016, 29(11):1176-1183. DOI: 10.1111/tri.12821.
|
| [20] |
NORIS M, RUGGENENTI P, REMUZZI G. Kidney transplantation in patients with atypical hemolytic uremic syndrome: a therapeutic dilemma (or not)? [J]. Am J Kidney Dis, 2017, 70(6):754-757. DOI: 10.1053/j.ajkd.2017.08.005.
|
| [21] |
FOWLER KJ. Progress in kidney transplantation: three recommendations[J]. Nephrol News Issues, 2016, 30(2):19-21. https://www.ncbi.nlm.nih.gov/pubmed/26983178
|
点击查看大图
下载:
